The trademark INVISIMASK was filed by Eureka Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 18, 2021, and received one opposition filed on July 15, 2021 by null on Likelihood of confusion. the opponent was represented by Whyatt, Bernard Anthony and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 15, 2021
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and address of the trademark registration was recorded on April 5, 2021.